Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT05061446 · COMPLETED
Trial details
- NCT number
- NCT05061446
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2023-10-06
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.